Resources

Selected
  • Systematic reviews (SYSVAC)
Type of publications
Regions
Diseases
Vaccine topics
Target population
Publication date

3152 results found

2025 ∙ Szondy, I. Lorincz, K. Walter, A. Mohammed, A. A. Hegyi, P. Kiss, N. Meznerics, F. A. Banvolgyi, A.

Evaluating cross-protection: Meningococcal vaccines show effectiveness in gonorrhoea prevention - A systematic review and meta-analysis

  • All age groups
  • Meningococcal disease
  • Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Critically low
2025 ∙ Jotautis, V. Sarantaki, A.

Evaluating the Efficacy and Safety of Hepatitis E Vaccination in Reproductive-Age Women: A Systematic Review and Meta-Analysis

  • Adolescents
  • Adults
  • Hepatitis E
  • Efficacy/effectiveness
  • Safety
Methodological quality (AMSTAR 2):
Critically low
2025 ∙ Alandijany, T. A. Qashqari, F. S.

Evaluating the efficacy, safety, and immunogenicity of FDA-approved RSV vaccines: a systematic review of Arexvy, Abrysvo, and mResvia

  • All age groups
  • Pregnant women
  • RSV (Respiratory syncytial virus)
  • Efficacy/effectiveness
  • Safety
  • Administration
Methodological quality (AMSTAR 2):
Low
2025 ∙ Siddiqui, E. Khan, M. S. Khalid, M. Chandani, H. K. Naeem, U. Khan, M. M. Wasti, S. O.

Evaluating the immunogenicity and safety of ID93 + GLA-SE in BCG-vaccinated healthy adults: a systematic review and meta-analysis of randomized controlled trials

  • Adults
  • Tuberculosis
  • Efficacy/effectiveness
  • Safety
Methodological quality (AMSTAR 2):
Critically low
2025 ∙ Williams, L. R. Hombach, J. Marti, M.

Evaluating the Immunogenicity, Efficacy, and Effectiveness of Recombinant Zoster Vaccine for Global Public Health Policy

  • All age groups
  • Herpes zoster
  • Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Critically low
2025 ∙ Zadeh Mehrizi, T. Eshrati, B. Ebrahimi Shahmabadi, H.

Evaluation of recent pre-booster studies on hepatitis B vaccine effectiveness across WHO regions with HBV prevalence above 1% in the general population up to 60 years of age: a systematic review

  • All age groups
  • Hepatitis B
  • Efficacy/effectiveness
  • Administration
Methodological quality (AMSTAR 2):
Critically low
2025 ∙ Sterian, M. Naganathan, T. Corrin, T. Waddell, L.

Evidence on the associations and safety of COVID-19 vaccination and post COVID-19 condition: An updated living systematic review

  • All age groups
  • COVID-19
  • Efficacy/effectiveness
  • Safety
  • Administration
Methodological quality (AMSTAR 2):
Critically low
2025 ∙ Larson, A. Shanmugam, P. Mitrovich, R. Vohra, D. Lansdale, A. J. Eiden, A. L.

Expanding vaccination provider types and administration sites can increase vaccination uptake: A systematic literature review of the evidence in non-United States geographies

  • All age groups
  • Coverage
Methodological quality (AMSTAR 2):
Not applicable
2025 ∙ Heinze, N. Martin, A. F. Tirion, A. S. C. Pae, R. Islam, J. Smith, L. E. Weston, D. Rubin, G. J.

Exploring the effectiveness of interventions to increase uptake of measles vaccination among healthcare workers: a systematic review

  • Healthcare workers
  • Adolescents
  • Adults
  • Older adults
  • Measles
  • Coverage
Methodological quality (AMSTAR 2):
Not applicable
2025 ∙ Abbasi, T. N. Khan, M. S. Siddiqui, E. Zaheer, M. A. Tabassum, A. Zainab, N. Waafira, A.

Exploring the safety and immunogenicity of the VLA15 vaccine among healthy or high-risk population: a systematic review and meta-analysis of randomized controlled trials

  • All age groups
  • Lyme disease, Borreliosis
  • Efficacy/effectiveness
  • Safety
  • Administration
Methodological quality (AMSTAR 2):
Critically low
Loading...